Sara Bystrup

Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway

Vicenç Ruiz de Porras, Sara Bystrup, Anna Martínez‐Cardús et al. · Scientific Reports · 2016 · 136 citations · Full text

Medicine, Oncology, Pharmacology +17

Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment

Vicenç Ruiz de Porras, Xieng C. Wang, Luís Palomero et al. · European Urology · 2020 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines

Alba Ginés, Sara Bystrup, Vicenç Ruiz de Porras et al. · PLoS ONE · 2015 · 38 citations · Full text

Medicine, Molecular Biology, Oncology +15

Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients

Vicenç Ruiz de Porras, Sara Bystrup, Sara Cabrero-de las Heras et al. · Cancers · 2019 · 20 citations · Full text

Medicine, Cancer Biology, Oncology +17

Isosteviol Has Beneficial Effects on Palmitate-Induced α-Cell Dysfunction and Gene Expression

Xiaoping Chen, Kjeld Hermansen, Jianzhong Xiao et al. · PLoS ONE · 2012 · 18 citations · Full text

Life Sciences, Endocrinology, Pharmacology +13